全文获取类型
收费全文 | 45291篇 |
免费 | 3934篇 |
国内免费 | 73篇 |
专业分类
耳鼻咽喉 | 636篇 |
儿科学 | 1366篇 |
妇产科学 | 1114篇 |
基础医学 | 6138篇 |
口腔科学 | 939篇 |
临床医学 | 5222篇 |
内科学 | 8301篇 |
皮肤病学 | 499篇 |
神经病学 | 3692篇 |
特种医学 | 1452篇 |
外国民族医学 | 3篇 |
外科学 | 6338篇 |
综合类 | 1002篇 |
一般理论 | 27篇 |
预防医学 | 5067篇 |
眼科学 | 1122篇 |
药学 | 3287篇 |
中国医学 | 67篇 |
肿瘤学 | 3026篇 |
出版年
2022年 | 266篇 |
2021年 | 660篇 |
2020年 | 451篇 |
2019年 | 716篇 |
2018年 | 773篇 |
2017年 | 577篇 |
2016年 | 624篇 |
2015年 | 746篇 |
2014年 | 1034篇 |
2013年 | 1544篇 |
2012年 | 2310篇 |
2011年 | 2380篇 |
2010年 | 1224篇 |
2009年 | 1181篇 |
2008年 | 2074篇 |
2007年 | 2313篇 |
2006年 | 2127篇 |
2005年 | 2134篇 |
2004年 | 2134篇 |
2003年 | 1890篇 |
2002年 | 1844篇 |
2001年 | 1314篇 |
2000年 | 1338篇 |
1999年 | 1198篇 |
1998年 | 655篇 |
1997年 | 549篇 |
1996年 | 540篇 |
1995年 | 503篇 |
1994年 | 382篇 |
1993年 | 335篇 |
1992年 | 910篇 |
1991年 | 828篇 |
1990年 | 802篇 |
1989年 | 778篇 |
1988年 | 739篇 |
1987年 | 671篇 |
1986年 | 737篇 |
1985年 | 685篇 |
1984年 | 566篇 |
1983年 | 457篇 |
1982年 | 360篇 |
1981年 | 314篇 |
1980年 | 333篇 |
1979年 | 539篇 |
1978年 | 378篇 |
1977年 | 331篇 |
1975年 | 285篇 |
1974年 | 342篇 |
1973年 | 336篇 |
1972年 | 293篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
M. R. D. Maslin S. K. Lloyd S. Rutherford S. Freeman A. King D. R. Moore K. J. Munro 《Journal of the Association for Research in Otolaryngology》2015,16(5):631-640
Individuals with sudden unilateral deafness offer a unique opportunity to study plasticity of the binaural auditory system in adult humans. Stimulation of the intact ear results in increased activity in the auditory cortex. However, there are no reports of changes at sub-cortical levels in humans. Therefore, the aim of the present study was to investigate changes in sub-cortical activity immediately before and after the onset of surgically induced unilateral deafness in adult humans. Click-evoked auditory brainstem responses (ABRs) to stimulation of the healthy ear were recorded from ten adults during the course of translabyrinthine surgery for the removal of a unilateral acoustic neuroma. This surgical technique always results in abrupt deafferentation of the affected ear. The results revealed a rapid (within minutes) reduction in latency of wave V (mean pre = 6.55 ms; mean post = 6.15 ms; p < 0.001). A latency reduction was also observed for wave III (mean pre = 4.40 ms; mean post = 4.13 ms; p < 0.001). These reductions in response latency are consistent with functional changes including disinhibition or/and more rapid intra-cellular signalling affecting binaurally sensitive neurons in the central auditory system. The results are highly relevant for improved understanding of putative physiological mechanisms underlying perceptual disorders such as tinnitus and hyperacusis. 相似文献
5.
Xiaoyan Lu Isabelle R. Miousse Sandra V. Pirela Jodene K. Moore Stepan Melnyk 《Nanotoxicology》2016,10(5):629-639
Evidence continues to grow on potential environmental health hazards associated with engineered nanomaterials (ENMs). While the geno- and cytotoxic effects of ENMs have been investigated, their potential to target the epigenome remains largely unknown. The aim of this study is two-fold: 1) determining whether or not industry relevant ENMs can affect the epigenome in vivo and 2) validating a recently developed in vitro epigenetic screening platform for inhaled ENMs. Laser printer-emitted engineered nanoparticles (PEPs) released from nano-enabled toners during consumer use and copper oxide (CuO) were chosen since these particles induced significant epigenetic changes in a recent in vitro companion study. In this study, the epigenetic alterations in lung tissue, alveolar macrophages and peripheral blood from intratracheally instilled mice were evaluated. The methylation of global DNA and transposable elements (TEs), the expression of the DNA methylation machinery and TEs, in addition to general toxicological effects in the lung were assessed. CuO exhibited higher cell-damaging potential to the lung, while PEPs showed a greater ability to target the epigenome. Alterations in the methylation status of global DNA and TEs, and expression of TEs and DNA machinery in mouse lung were observed after exposure to CuO and PEPs. Additionally, epigenetic changes were detected in the peripheral blood after PEPs exposure. Altogether, CuO and PEPs can induce epigenetic alterations in a mouse experimental model, which in turn confirms that the recently developed in vitro epigenetic platform using macrophage and epithelial cell lines can be successfully utilized in the epigenetic screening of ENMs. 相似文献
6.
7.
A. Cattapan K. Browne D.M. Halperin A. Di Castri P. Fullsack J. Graham J.M. Langley B.A. Taylor S.A. McNeil S.A. Halperin 《Vaccine》2019,37(2):289-295
Introduction/Hypothesis
Recruitment of participants into phase 1 vaccine clinical trials can be challenging since these vaccines have not been used in humans and there is no perceived benefit to the participant. Occasionally, as was the case with a phase 1 clinical trial of an Ebola vaccine in Halifax, Canada, during the 2014–2016 West African Ebola virus outbreak, recruitment is less difficult. In this study, we explored the motivations of participants in two phase 1 vaccine trials that were concurrently enrolling at the same centre and compared the motivations of participants in a high-profile phase 1 Ebola vaccine trial to those in a less high-profile phase 1 adjuvanted seasonal influenza vaccine study.Methods
An online survey which included participants’ prior experience with clinical trials, motivations to participate (including financial incentives), and demographic information was developed to examine the motivations of healthy participants in two phase 1 clinical vaccine trials conducted at the Canadian Center for Vaccinology in Halifax, Nova Scotia. Participants were invited via email to complete the online survey. Readability and clarity were assessed through pilot testing.Results
A total of 49 (55.7%) of 88 participants of the two studies completed the survey (22 [55%] of 40 participants from the Ebola vaccine study and 27 [56.3%] of 48 from the adjuvanted influenza vaccine study). Motivations that were most frequently ranked among participants' top three in both trials were (1) wanting to contribute to the health of others, (2) wanting to participate in something important, (3) wanting to contribute to the advancement of science, and (4) wanting to receive an incentive such as money or a tablet.Conclusions/Recommendations
Although media attention and financial compensation were more often cited by Ebola vaccine trial participants as a reason to participate, both altruistic and self-interested factors were important motivations for participants in their decision to participate in a phase 1 vaccine clinical trial. 相似文献8.
9.
10.